Keymed Biosciences Inc. (HKG:2162)
Hong Kong
· Delayed Price · Currency is HKD 53.60
+2.50 (4.89%)
Mar 10, 2026, 11:04 AM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 15.05 billion as of March 9, 2026. Its market cap has increased by 56.74% in one year.
Market Cap
15.05B
Enterprise Value
12.95B
Revenue
955.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
53.60
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has decreased from 18.43B to 15.05B, a decrease of -18.31%. That is a compound annual growth rate of -4.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 15.05B | -4.40% |
| Dec 31, 2025 | 15.75B | 84.90% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascletis Pharma | 15.28B |
| Ascentage Pharma Group International | 16.66B |
| Zai Lab | 17.13B |
| Everest Medicines | 12.98B |
| Guangzhou Innogen Pharmaceutical Group | 11.05B |
| Nanjing Leads Biolabs | 10.71B |
| PegBio | 23.50B |
| HBM Holdings | 10.08B |